Stulc, Tomáš
Ceška, Richard
Gotto, Antonio M. Jr.
Article History
First Online: 21 October 2015
Compliance with Ethical Standards
:
: Tomáš Štulc and Richard Češka declare that they have no conflict of interest.Antonio M. Gotto Jr. declares personal fees from Aegerion Pharmaceuticals, Arisaph Pharmaceuticals, DuPont, Esperion Therapeutics, KOWA, Merck, Roche, Vatera Capital, and ISIS Pharmaceuticals for various boards of directors, advisory boards, consultancies, and data safety monitoring board duties.
: This article does not contain any studies with human or animal subjects performed by any of the authors.